Meeting
2017 ASCO Annual Meeting
Risk stratification of smoldering multiple myeloma (SMM): Predictive value of free light chains and group-based trajectory modeling (GBTM).
Authors
Ajai Chari
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
Ajai Chari , Vernon Wu , Erin Moshier
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Plasma Cell Dyscrasia
Track
Hematologic Malignancies—Plasma Cell Dyscrasia
Sub Track
Multiple Myeloma
Citation
J Clin Oncol 35, 2017 (suppl; abstr 8031)
DOI
10.1200/JCO.2017.35.15_suppl.8031
Abstract #
8031
Poster Bd #
357
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Evaluating serum-free light chain ratio as a biomarker for multiple myeloma.
First Author: Theresia Akhlaghi
Poster
2022 ASCO Annual Meeting
African American patients with smoldering multiple myeloma may have a lower risk of progression compared to White patients.
First Author: Theresia Akhlaghi
Poster
2014 ASCO Annual Meeting
Free light chain assay and cytogenetic abnormalities for identification of high-risk smoldering myeloma.
First Author: Jeremy Todd Larsen
Poster
2023 ASCO Annual Meeting
Three-dimensional telomere profiling to predict risk of progression in smoldering multiple myeloma.
First Author: Shaji Kumar